Parkinson's disease (PD) is a progressive neurodegenerative movement disorder frequently associated with a wide variety of non-motor symptoms related to non-dopaminergic pathways. Although the depletion of dopamine is the key neurochemical impairment in PD and anticholinergic medications are used for symptomatic treatment, significant deficits in cholinergic transmission are also present and have been associated with cognitive decline and gait dysfunction. Therefore, use of a cholinesterase inhibitor (ChI) might improve cognitive function and reduce the risk of falls in patients with PD, although it could plausibly worsen motor features. Our objective was to conduct a systematic review of prospective, randomised controlled trials, in order to assess the efficacy and safety of ChIs compared with placebo in patients with PD.

Cholinesterase inhibitors for Parkinson's disease: a systematic review and meta-analysis / Pagano, Gennaro; Rengo, Giuseppe; Pasqualetti, Giuseppe; Femminella, GRAZIA DANIELA; Monzani, Fabio; Ferrara, Nicola; Tagliati, Michele. - In: JOURNAL OF NEUROLOGY, NEUROSURGERY AND PSYCHIATRY. - ISSN 0022-3050. - 86:7(2015), pp. 767-773. [10.1136/jnnp-2014-308764]

Cholinesterase inhibitors for Parkinson's disease: a systematic review and meta-analysis

PAGANO, GENNARO;RENGO, GIUSEPPE;FEMMINELLA, GRAZIA DANIELA;FERRARA, NICOLA;
2015

Abstract

Parkinson's disease (PD) is a progressive neurodegenerative movement disorder frequently associated with a wide variety of non-motor symptoms related to non-dopaminergic pathways. Although the depletion of dopamine is the key neurochemical impairment in PD and anticholinergic medications are used for symptomatic treatment, significant deficits in cholinergic transmission are also present and have been associated with cognitive decline and gait dysfunction. Therefore, use of a cholinesterase inhibitor (ChI) might improve cognitive function and reduce the risk of falls in patients with PD, although it could plausibly worsen motor features. Our objective was to conduct a systematic review of prospective, randomised controlled trials, in order to assess the efficacy and safety of ChIs compared with placebo in patients with PD.
2015
Cholinesterase inhibitors for Parkinson's disease: a systematic review and meta-analysis / Pagano, Gennaro; Rengo, Giuseppe; Pasqualetti, Giuseppe; Femminella, GRAZIA DANIELA; Monzani, Fabio; Ferrara, Nicola; Tagliati, Michele. - In: JOURNAL OF NEUROLOGY, NEUROSURGERY AND PSYCHIATRY. - ISSN 0022-3050. - 86:7(2015), pp. 767-773. [10.1136/jnnp-2014-308764]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/617054
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 106
  • ???jsp.display-item.citation.isi??? 82
social impact